The effect and characterizations of silver nanoparticles on biofilm formation in Pseudomonas aeruginosa isolated from UTIs patients
Keywords:
UTIs, P. aeruginosa, silver nanoparticles, biofilmAbstract
Background: Urinary tract infection (UTI) is a common health problem in both community and nosocomial settings, affecting both men and women equally.Pseudomonas aeruginosa is an opportunistic human pathogen causing devastating acuteand chronic infections in individuals with compromised immune systems. Biofilmis an architecture built mostly by autogenic extracellular polymeric substances which function asa scaffold to encase the bacteria together on surfaces, and to protect them from environmentalstresses, impedes phagocytosis and thereby conferring the capacity for colonization and long-termpersistence.The present study aim to evaluate the antibacterial activity of chemo-synthesized AgNPs onbiofilm-forming XDR Pseudomonas aeruginosaisolated from UTIs patients. Methods: These study was conducted in Al-Qadisiyah province, Iraq at five major hospitals (AL-Diwanyia Teaching Hospital,Feminine and children teaching hospital, Afak General Hospital, AL-Hamzah General Hospital and AL-Shamiya General Hospital) during the period from (November, 2020 to June, 2021). A total of 800 urine samples were collected from male and females referring to five major hospitals. The age of the patients ranged from (1 to 80) years-old. Results:Sixty isolates were showed positive and identified as P. aeruginosa by using selective media, biochemical test system and VITEK-2 compact system. Genetically, in the present study, a total DNA was extracted from all clinical P.aeruginosa isolates.
Downloads
References
Foxman, B.(2020). Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North America., 28 (1):1-13.
Dunne, M. W., Puttagunta, S., Aronin, S. I., Brossette, S., Murray, J., & Gupta, V. (2022). Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales. Microbiology spectrum, 10(1), e02359-02321.
Gomila, A.; Carratalà, J.; Badia, J.M.; Camprubí, D.; Piriz, M.; Shaw, E.; Diaz-Brito, V.; Espejo, E.; Nicolás, C.; Brugués, M.; et al. (2018). Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: A multicenter prospective cohort study. BMC Infect. Dis, 18, 507.
Galdino, A. C. M., Branquinha, M. H., Santos, A. L., & Viganor, L. (2017). Pseudomonas aeruginosa and its arsenal of proteases: weapons to battle the host. Pathophysiological Aspects of proteases, 381-397.
Ghafoor, A.; Hay, I.D.; Rehm, B.H. (2011).Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formationand architecture. Appl. Environ. Microbiol., 77, 5238–5246.
Crespo, A.; Blanco-Cabra, N.; Torrents, E. (2018).Aerobic Vitamin B12 Biosynthesis Is Essential for Pseudomonasaeruginosa Class II Ribonucleotide Reductase Activity During Planktonic and Biofilm Growth. Front. Microbiol., 9, 986.
Oluyombo, O.; Penfol. M d, C.N.; Diggle, S.P. (2019).Competition in Biofilms between Cystic Fibrosis Isolates ofPseudomonas aeruginosais Shaped by R-Pyocins. mBio, 10, e01828-18.
Pang, Z.; Raudonis, R.; Glick, B.R.; Lin, T.J.; Cheng, Z. (2019).Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol. Adv., 37, 177–192.
Moradali, M.F.; Ghods, S.; Rehm, B.H. (2017).Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front. Cell Infect. Microbiol,7, 39.
Romling, U.; Balsalobre, C. (2012).Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med, 272, 541–561.
M. Radzig, V.A. Nadtochenko, O.A. Koksharova, et al., (2013). Antibacterial effects of silver nanoparticles on gramnegative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids and Surfaces B: Biointerfaces, 102: 300-306.
M. Prabakaran, K.V. Nithya, P. Gajendiran, et al., (2018). Green synthesis of piperine/triton X-100/silver nanoconjugates:antimicrobial activity and cytotoxicity. Nano Biomedicine and Engineering, 10(2): 141-148.
S.O. Hasson, M.J. Al-Awady, A.H. Al-Hamadani, et al., Boosting antimicrobial activity of imipenem incombination with silver nanoparticles towards S. fonticolaand Pantoea sp. Nano Biomed. Eng., 2019, 11(2): 200-214.
Theivasanthi, M. Alagar, (2011). Anti-bacterial studies of silver nanoparticles. arXiv.org,: arXiv:1101.0348 [physics.gen-ph].
M.J. Al-Awady, A.A.J.N.B.E. Balakit, (2019). Investigation of anti-MRSA and anticancer activity of eco-friendly synthesized silver nanoparticles from palm dates extract. Nano Biomed. Eng., 10(2): 157-169.
G. Sharma, A.S. Kumar, S. Naushad, et al., (2017). Novel development of nanoparticles to bimetallic nanoparticles and their composites: A review. Journal of King Saud University-Science.
S. Tang, J. Zheng, Antibacterial activity of silver nanoparticles: Structural effects. Advanced Healthcare Materials, 2018: 1701503.
MacFaddin, J.F. (2004).Biochemical tests for identification of medical bacteria (7rd ed.), Lippincott Williams and Wilkins, USA.
Daragon, B., Fournier, D., Plésiat, P., & Jeannot, K. (2021). Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 76(10), 2586-2592.
Banerjee, G. (2014). Comparative Study of Biofilm Formation in Pseudomonas aeruginosa isolates from Patients of Lower Respiratory Tract Infection. Journal of clinical and diagnostic research, 8(5), 9–11.
Babiker, K.S.; Idrees, D.A.; Alumagadam, T. M.(2020). Efficacy of propolis extract against S. aureus, P. aeruginosa, and K. pneumoniae strains isolated from patients with wound infection. Pharmacy & Pharmacology International Journal. 8(5): 269-272.
Ahamad, I., Aziz, N., Zaki, A., & Fatma, T. (2021). Synthesis and characterization of silver nanoparticles using Anabaena variabilis as a potential antimicrobial agent. Journal of Applied Phycology, 33(2), 829-841.
Bajracharya, A.; Pawar, D., Mourya, P. and Patil, A. (2018). Bacterial synthesis of silver nanoparticles. World Journal of Pharmaceutical research. 7(6):872-887.
Prasad, K.S.; D.Pathak; A.Patel; P. Dalwadi; R. Prasad; P. Patel, and K. Selvaraj. (2011). Biogenic synthesis of silver nanoparticles using Nicotiana tobaccum leaf extract and study of their antibacterial effect. Afr J Biotechnol., 10 (41): 8122.
BAKIR, Ö., Güller, P., & KURBANOĞLU, E. B. (2022). Synthesis, characterization, antibacterial, antioxidant activity, and lipoxygenase enzyme inhibition profile of silver nanoparticles (AgNPs) by green synthesis from Seseli resinosum Freyn & Sint. International Journal of Plant Based Pharmaceuticals, 2(2), 182-189.
Zhang, X.-F.; Liu, Z.-G.; Shen, W. and Gurunathan, S. (2016). Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. International Journal of Molecular Sciences, 17(9), 1534.
Aabed, K., and Mohammed, A. E. (2021). Synergistic and Antagonistic Effects of Biogenic Silver Nanoparticles in Combination with Antibiotics Against Some Pathogenic Microbes. Frontiers in Bioengineering and Biotechnology, 9, 249.
McDonald, J.H. (2014). Handbook of Biological Statistics. 3rd ed. USA: Sparky House Publishing.
Belal, E. J. K. (2010). Investigation of some B-Lactamases in Clinical Isolates of Pseudomonas aeruginosa in Najaf City. M.Sc. Thesis. Edication of Girls/ University of Kufa. Iraq.
Abdul-Wahid, Ali, A. (2020). Antibiotic Sensitivity and Molecular Profile of Carbapenemase-Producing Pseudomonas aeruginosa from hospital-acquired infections in Thi-Qar province. PhD. Thesis, College of Medicine, University of Al-Qadissiyah.
Clinical and Laboratory Standards Institute (CLSI).(2020). Performance standards for antimicrobial susceptibility testing. CLSI supplement M100, 30th. Ed. Clinical and Laboratory Standards Institute, Wayne, PA.
Muderris, T.; Durmaz, R. and Ozdem, B. (2018). Role of efflux pump and OprD porin expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. J Infect Dev. Ctries. 12(1):1–8.
Al-Janahi, Haider C. L. (2020).Occurrence and Molecular Characterization of Metallo-β-Lactamase (MBLs)-Producing Pseudomonas aeruginosa in Najaf Hospitals. MSc. Thesis, Faculty of Medicine, University of Kufa.
Al-kazrage, Hussein A. D. (2021).Inhibition of Virulence Factors in Pseudomonas aeruginosa Isolated from Clinical Samples Using Galardin Loaded AgPEG Nanocomposite. PhD. Thesis, College of Biotechnology, University of Al-Nahrain.
Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A (2020). Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Research Notes 13(1): 27.
Abdelraheem, W. M., Abdelkader, A. E., Mohamed, E. S., & Mohammed, M. S. (2020). Detection of biofilm formation and assessment of biofilm genes expression in different Pseudomonas aeruginosa clinical isolates. Meta Gene, 23, 100646.
Ciofu O, Tolker-Nielsen T (2019). Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents-how P. aeruginosa can escape antibiotics. Frontiers in microbiology 10: 913.
Muthukrishnan, S., Bhakya, S., Senthil Kumar, T. and Rao, M.V. (2015) 'Biosynthesis,characterization and antibacterial effect of plant-mediated silver nanoparticles usingCeropegiathwaitesii – An endemic species', Industrial Crops and Products, 63, pp. 119-124.
De Leersnyder, I., Rijckaert, H., De Gelder, L., Van Driessche, I., & Vermeir, P. (2020). High variability in silver particle characteristics, silver concentrations, and production batches of commercially available products indicates the need for a more rigorous approach. Nanomaterials, 10(7), 1394.
Ulagesan, S., Nam, T.-J., & Choi, Y.-H. (2021). Biogenic preparation and characterization of Pyropia yezoensis silver nanoparticles (Py AgNPs) and their antibacterial activity against Pseudomonas aeruginosa. Bioprocess and Biosystems Engineering, 44(3), 443-452.
Zhang, X., Zhang, Z., Wu, W., Yang, J., & Yang, Q. (2021). Preparation and characterization of chitosan/Nano-ZnO composite film with antimicrobial activity. Bioprocess and Biosystems Engineering, 44(6), 1193-1199.
Gavamukulya, Y., Maina, E. N., Wamunyokoli, F., Meroka, A. M., Madivoli, E. S., El-Shemy, H. A., & Magoma, G. (2019).Synthesis and Characterization of Silver Nanoparticles from Ethanolic Extracts of Leaves of Annona muricata: A Green Nanobiotechnology Approach. Biotechnol. J. Int, 4, 1-18.
Samuggam, S., Chinni, S. V., Mutusamy, P., Gopinath, S. C., Anbu, P., Venugopal, V., Reddy, L. V., & Enugutti, B. (2021). Green Synthesis and Characterization of Silver Nanoparticles Using Spondias mombin Extract and Their Antimicrobial Activity against Biofilm-Producing Bacteria. Molecules, 26(9), 2681.
Pham, T. T. H., Vu, X. H., Trinh, D. K., Nguyen, D. D., Luong, D. T., Nguyen, Q. H., & Luong, V. L. (2021). Synthesis and Characterization of Silver Nanoparticles for Antibacterial Application against Bacillus Subtilis and Pseudomonas Aeruginosa. VNU Journal of Science: Mathematics-Physics, 37(2).
Zubair, M., Azeem, M., Mumtaz, R., Younas, M., Adrees, M., Zubair, E., Khalid, A., Hafeez, F., Rizwan, M., & Ali, S. (2022). Green synthesis and characterization of silver nanoparticles from Acacia nilotica and their anticancer, antidiabetic and antioxidant efficacy. Environmental Pollution, 304, 119249.
Beeler, E., Choy, N., Franks, J., Mulcahy, F., & Singh, O. V. (2020). Extracellular Synthesis and Characterization of Silver Nanoparticles from Alkaliphilic Pseudomonas sp. Journal of Nanoscience and Nanotechnology, 20(3), 1567-1577.
Al-Tameme, S.A. (2017). The Antimicrobial Effect of Silver NanoParticles (AgNPs) Against Pseudomonas aeruginosa Isolated from Clinical Samples. M.Sc.
Raheem, H.Q., Al-Thahab, A. and Abd, F.G. (2018). 'Antibacterialactivity of silver nanoparticles extracted from Proteus mirabilis andhealing the wound in rabbit', Biochemical and CellularArchives, 18(1), pp. 97-104.
Masoumi, S., and Shakibaie, M. R. (2018). Evaluation Synergistic Effect ofTiO2, AgNPs Nanoparticles and Amphiphilic Peptides (Mastoparan-B, Indolicidin)Against Drug-Resistant Pseudomonas aeruginosa, Klebsiella pneumoniae andAcinetobacter baumannii.
Singh P, Pandit S, Garnæs J, Tunjic S, Mokkapati VR, Sultan A, Thygesen A, Mackevica A, Mateiu RV, Daugaard AE, Baun A (2018). Green synthesis of gold and silver nanoparticles from Cannabis sativa (industrial hemp) and their capacity for biofilm inhibition. Int J Nanomedicine 13:3571–3591.
Garg, D., Sarkar, A., Chand, P., Bansal, P., Gola, D., Sharma, S., Khantwal, S., Mehrotra, R., Chauhan, N., & Bharti, R. K. (2020). Synthesis of silver nanoparticles utilizing various biological systems: mechanisms and applications—a review. Progress in Biomaterials, 9(3), 81-95.
Al-Obaidi H, Kalgudi R, Zariwala MG (2018). Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa. Eur J Pharm Biopharm 128:27–35.
Bose D, Chatterjee S. (2016). Biogenic synthesis of silver nanoparticles using guava (Psidium guajava) leaf extract and its antibacterial activity against Pseudomonas aeruginosa. Appl Nanosci6 (6):895–901.
Erjaee, H., Rajaian, H., & Nazifi, S. (2017). Synthesis and characterization of novel silver nanoparticles using Chamaemelum nobile extract for antibacterial application. Advances in Natural Sciences: Nanoscience and Nanotechnology, 8(2), 025004.
Parmin, P., Suarayasa, K., & Wandira, B. A. (2020). Relationship between quality of service with patient loyality at general polyclinic of kamonji public health center. International Journal of Health & Medical Sciences, 3(1), 86-91. https://doi.org/10.31295/ijhms.v3n1.157
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
